{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:26:21Z","timestamp":1700267181297},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In this qualitative analysis we aimed to explore addiction physicians\u2019 perspectives on safer injection education for people who inject drugs, especially: (1) on possible means of introducing safer injection education in the medical environment, (2) on the compatibility of safer injection education with each physician\u2019s core values and goals, and (3) on possible reasons for the ethical dilemma in safer injection education.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted semi-structured interviews with eleven physicians practicing addiction medicine in France in clinical and harm reduction settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All participants were in favor of educational interventions for people who inject drugs. Nonetheless, these interventions varied from simple advice to injection supervision and they were seen as less acceptable when they concerned the practical and material aspects of injection. Some participants found that physicians practicing in clinical settings, where patients consult mostly to stop their drug use, should not practice safer injection education. On the contrary, other participants claimed that safer injection education was essential in all settings and was not a choice but rather a duty for addiction physicians. The ethical dilemma of such intervention when delivered by medical staff was viewed as a complex phenomenon, related to the representations of intravenous drug use and to societal expectations from physicians.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Physicians\u2019 views on safer injection education for people who inject drugs reveal an emotionally charged subject related to the structural organization of addiction management in France. Such education is marked by an arduous history of harm reduction policies in France.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>IRB registration:<\/jats:title>\n                <jats:p>#00011928.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12910-023-00939-4","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T18:02:23Z","timestamp":1691776943000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A qualitative study of professionals\u2019 perspectives on the ethics of medically-delivered safer injection education for people who inject drugs"],"prefix":"10.1186","volume":"24","author":[{"given":"Anastasia","family":"Demina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Despr\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Mamzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"647","key":"939_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3399\/bjgp16X685333","volume":"66","author":"C Cornford","year":"2016","unstructured":"Cornford C, Close H. The physical health of people who inject drugs: complexities, challenges, and continuity. Br J Gen Pract juin. 2016;66(647):286\u20137.","journal-title":"Br J Gen Pract juin"},{"issue":"1","key":"939_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13011-020-00321-2","volume":"15","author":"MT Munoz Sastre","year":"2020","unstructured":"Munoz Sastre MT, Kpanake L, Mullet E. French people\u2019s positions on supervised injection facilities for drug users. Subst Abuse Treat Prev Policy d\u00e9c. 2020;15(1):79.","journal-title":"Subst Abuse Treat Prev Policy d\u00e9c"},{"issue":"1","key":"939_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12954-021-00523-2","volume":"18","author":"S Tun","year":"2021","unstructured":"Tun S, Vicknasingam B, Singh D. Factors affecting addiction severity index (ASI) among clients enrolled in methadone maintenance treatment (MMT) program in Myanmar. Harm Reduct J 5 ao\u00fbt. 2021;18(1):84.","journal-title":"Harm Reduct J 5 ao\u00fbt"},{"key":"939_CR4","unstructured":"Inserm. R\u00e9duction des risques chez les usagers de drogues. Available from: https:\/\/www.ipubli.inserm.fr\/handle\/10608\/86."},{"key":"939_CR5","unstructured":"Cordonnier JP, Touzeau D, Charles-Nicolas A. La seringue et le sida. Ann Med-Psycho. 1988."},{"key":"939_CR6","first-page":"63","volume":"2","author":"F Arnold Richez","year":"2004","unstructured":"Arnold Richez F. History, stories\u2026 risk reduction and a mean of survival. Le Courrier de addictions. 2004;2:63\u201370.","journal-title":"Le Courrier de addictions"},{"key":"939_CR7","doi-asserted-by":"crossref","unstructured":"Marchant A. L\u2019impossible prohibition. Perrin; 2018.","DOI":"10.3917\/perri.march.2018.01"},{"issue":"5","key":"939_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0277-9536(94)00435-V","volume":"41","author":"GV Stimson","year":"1995","unstructured":"Stimson GV. Aids and injecting drug use in the United Kingdom, 1987\u20131993: the policy response and the prevention of the epidemic. Soc Sci Med sept. 1995;41(5):699\u2013716.","journal-title":"Soc Sci Med sept"},{"key":"939_CR9","unstructured":"Jayle D, Pialoux G. Guerres \u00e0 la drogue en Europe. SWAPS 88\u201389. 2018."},{"issue":"1","key":"939_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/add.13089","volume":"111","author":"P Roux","year":"2016","unstructured":"Roux P, Le Gall JM, Debrus M, Protopopescu C, Ndiaye K, Demoulin B, et al. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS\u2013AERLI intervention study. Addiction. 2016;111(1):94\u2013106.","journal-title":"Addiction"},{"key":"939_CR11","unstructured":"Loi n\u00b0. 2016-41 du 26 janvier 2016 de modernisation de notre syst\u00e8me de sant\u00e9 - Dossiers l\u00e9gislatifs - L\u00e9gifrance."},{"key":"939_CR12","unstructured":"Inserm. Salles de consommation \u00e0 moindre risque: rapport scientifique \u2013 Mai 2021 \u22c5 Inserm, La science pour la sant\u00e9. Available from: https:\/\/www.inserm.fr\/rapport\/salles-de-consommation-a-moindre-risque-rapport-scientifique-mai-2021\/."},{"issue":"2","key":"939_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/14780887.2015.1119228","volume":"13","author":"S Parkinson","year":"2016","unstructured":"Parkinson S, Eatough V, Holmes J, Stapley E, Midgley N. Framework analysis: a worked example of a study exploring young people\u2019s experiences of depression. Qual Res Psychol 2 avr. 2016;13(2):109\u201329.","journal-title":"Qual Res Psychol 2 avr"},{"issue":"4","key":"939_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/add.12857","volume":"110","author":"J Neale","year":"2015","unstructured":"Neale J, West R. Guidance for reporting qualitative manuscripts: Editorial note. Addict avr. 2015;110(4):549\u201350.","journal-title":"Addict avr"},{"key":"939_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugpo.2018.04.014","volume":"56","author":"M Jauffret-Roustide","year":"2018","unstructured":"Jauffret-Roustide M, Cailbault I. Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in french public debate. Int J Drug Policy juin. 2018;56:208\u201317.","journal-title":"Int J Drug Policy juin"},{"key":"939_CR16","unstructured":"Article R. 4127-3 - Code de la sant\u00e9 publique. Code de la sant\u00e9 publique. Sect. Code de d\u00e9ontologie m\u00e9dicale ao\u00fbt 8, 2004. L\u00e9gifrance."},{"key":"939_CR17","unstructured":"Kempfer J, Marchant A. Du clyst\u00e8re \u00e0 la seringue: l\u2019injection \u00e0 travers l\u2019histoire. SWAPS 75e \u00e9d. 2014."},{"key":"939_CR18","unstructured":"L\u00e9pine P, Voinot J. Une br\u00e8ve histoire de la seringue. Histoire des sciences m\u00e9dicales. 2010; 49\u201353."},{"key":"939_CR19","unstructured":"Robert C. A history of syringes and needles, University of Queensland. 2018. Available from: https:\/\/medicine.uq.edu.au\/blog\/2018\/12\/history-syringes-and-needles."},{"issue":"4","key":"939_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/add.13214","volume":"111","author":"R McNeil","year":"2016","unstructured":"McNeil R, Kerr T, Pauly B, Wood E, Small W. Advancing patient-centered care for structurally vulnerable drug\u2010using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals. Addict avr. 2016;111(4):685\u201394.","journal-title":"Addict avr"},{"key":"939_CR21","unstructured":"Foucault M, Paris. Gallimard; 1999. 351."},{"key":"939_CR22","first-page":"215","volume-title":"Outsiders: studies in the sociology of deviance. New ed","author":"HS Becker","year":"1997","unstructured":"Becker HS. Outsiders: studies in the sociology of deviance. New ed. New York, NY: Free; 1997. p. 215."},{"issue":"1","key":"939_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2307\/3321642","volume":"27","author":"I Baszanger","year":"1986","unstructured":"Baszanger I. Les maladies chroniques et leur ordre n\u00e9goci\u00e9. Rev Fr Sociol. 1986;27(1):3\u201327.","journal-title":"Rev Fr Sociol"},{"issue":"1","key":"939_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3917\/mult.044.0078","volume":"44","author":"A Coppel","year":"2011","unstructured":"Coppel A. Drogues et m\u00e9dicalisation: entre expertise et demande sociale. Multitudes. 2011;44(1):78.","journal-title":"Multitudes"},{"key":"939_CR25","doi-asserted-by":"crossref","unstructured":"Coppel A. Une rupture du consensus sur la guerre \u00e0 la drogue ? Rhizome 2016;N 62(4):7.","DOI":"10.3917\/rhiz.062.0007"},{"issue":"1","key":"939_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12954-017-0177-7","volume":"14","author":"E Hyshka","year":"2017","unstructured":"Hyshka E, Anderson-Baron J, Karekezi K, Belle-Isle L, Elliott R, Pauly B, et al. Harm reduction in name, but not substance: a comparative analysis of current canadian provincial and territorial policy frameworks. Harm Reduct J d\u00e9c. 2017;14(1):50.","journal-title":"Harm Reduct J d\u00e9c"},{"issue":"1","key":"939_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-017-0178-6","volume":"14","author":"DC Des Jarlais","year":"2017","unstructured":"Des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J d\u00e9c. 2017;14(1):51.","journal-title":"Harm Reduct J d\u00e9c"},{"issue":"1","key":"939_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12954-020-00452-6","volume":"17","author":"A Davitadze","year":"2020","unstructured":"Davitadze A, Meylakhs P, Lakhov A, King EJ. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work. Harm Reduct J d\u00e9c. 2020;17(1):98.","journal-title":"Harm Reduct J d\u00e9c"},{"issue":"4","key":"939_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/QAD.0000000000003441","volume":"37","author":"Z Nikoloski","year":"2023","unstructured":"Nikoloski Z, King EJ, Mossialos E. HIV in the Russian Federation: mortality, prevalence, risk factors, and current understanding of sexual transmission. AIDS 15 mars. 2023;37(4):637\u201345.","journal-title":"AIDS 15 mars"},{"issue":"1","key":"939_CR30","first-page":"58","volume":"136","author":"F Brug\u00e8re","year":"2014","unstructured":"Brug\u00e8re F. Qu\u2019est-ce que prendre soin aujourd\u2019hui ? Cah Philos 21 janv. 2014;136(1):58\u201368.","journal-title":"Cah Philos 21 janv"}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-023-00939-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12910-023-00939-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-023-00939-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:08:46Z","timestamp":1700237326000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/s12910-023-00939-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1186\/s12910-023-00939-4","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Assistance Publique \u2013 H\u00f4pitaux de Paris Ethics Committee granted approval for this study (IRB registration: #00011928). All methods were performed in accordance with the relevant guidelines and regulations. All participants provided their informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"IRB registration: #00011928.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registration details"}}],"article-number":"63"}}